4basebio (LSE:4BB) ROCE % : -74.38% (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is 4basebio ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. 4basebio's annualized ROCE % for the quarter that ended in Jun. 2023 was -74.38%.

4basebio ROCE % Historical Data

The historical data trend for 4basebio's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4basebio ROCE % Chart

4basebio Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

ROCE %

-71.31

-7.07

-23.38

-50.02

4basebio Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
ROCE %	Get a 7-Day Free Trial			-22.92	-24.56	-45.33	-59.71	-74.38

4basebio ROCE % Calculation

4basebio's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	-5.84	/	( ( (14.702 - 1.523)	+	(11.689 - 1.518) )	/ 2 )
	=	-5.84	/	( (13.179	+	10.171)	/ 2 )
	=	-5.84	/	11.675
	=	-50.02 %

4basebio's ROCE % of for the quarter that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2023 )		(Q: Dec. 2022 )		(Q: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2023 )		(Q: Dec. 2022 )		(Q: Jun. 2023 )
	=	-7.528	/	( ( (11.689 - 1.518)	+	(11.556 - 1.484) )	/ 2 )
	=	-7.528	/	( ( 10.171	+	10.072 )	/ 2 )
	=	-7.528	/	10.1215
	=	-74.38 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2023) EBIT data.

4basebio (LSE:4BB) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

4basebio ROCE % Related Terms

Thank you for viewing the detailed overview of 4basebio's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

4basebio (LSE:4BB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (LSE:4BB) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

88Q:Germany

Address

25 Norman Way, Over, Cambridge, GBR, CB24 5QE

Website

https://www.4basebio.com

4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio (LSE:4BB) Headlines

No Headlines